Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duration of Doxycycline in Erythema Migrans
NCT03153267Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jun 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of doxycycline in erythema migrans (EM) (3 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Treatment outcome in patients treated for erythema migrans at 12 months. Started Jun 2017; status: completed.
02
Drugs
doxycycline
03
Conditions
erythema migrans (EM)
Beyond the preview
Go deeper on NCT03153267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03153267.